A Versatile Stability-indicating Liquid Chromatographic Method for the Simultaneous Determination of Atenolol, Hydrochlorothiazide and Chlorthalidone

Author(s): Ehab Farouk Elkady, Marwa Ahmed Fouad, Abdulgabar A. Ezzy Faquih*

Journal Name: Current Pharmaceutical Analysis

Volume 16 , Issue 8 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Atenolol is a selective beta 1 blocker that can be used alone or in combination with hydrochlorothiazide or with chlorthalidone for the treatment of hypertension and prevention from a heart attack.

Objective: The main target of this work was to improve modern, easy, accurate and selective liquid chromatographic method (RP-HPLC) for the determination of these drugs in the presence of their degradation products. These methods can be used as analytical gadgets in quality control laboratories for a routine examination.

Methods: In this method, the separation was accomplished through an Inertsil® ODS-3V C18 column (250 mm x 4.6 mm, 5 μm), the mobile phase used was 25 mM aqueous potassium dihydrogen orthophosphate solution adjusted to pH 6.8 by using 0.1M sodium hydroxide and acetonitrile (77 : 23, v/v), the flow rate used was 1 ml/min and detection was achieved at 235 nm using UV.

Results: All peaks were sharp and well separated, the retention times were atenolol degradation (ATN Deg.) 2.311 min, atenolol (ATN) 2.580 min, hydrochlorothiazide degradation (HCT Deg.) 5.890 min, hydrochlorothiazide (HCT) 7.016 min, chlorthalidone degradation CTD Deg 8.018 min and chlorthalidone (CTD) 14.972 min. Linearity was obtained and the range of concentrations was 20- 160 μg/ml for atenolol, 10-80 μg/ml for hydrochlorothiazide and 10-80 μg/ml for chlorthalidone. According to ICH guidelines, method validation was accomplished, these methods include linearity, accuracy, selectivity, precision and robustness.

Conclusion: The optimized method demonstrated to be specific, robust and accurate for the quality control of the cited drugs in pharmaceutical dosage forms.

Keywords: Atenolol, hydrochlorothiazide, chlorthalidone, reversed phase liquid chromatography, pharmaceutical preparations.

[1]
Goodman Gilman, A.; Hardman, J.G.; Limbird, L.W. Goodman & Gilman’s the pharmacological basis of therapeutics, 11th ed; McGraw-Hill, 2006.
[2]
Remington, J.P. Remington: the science and practice of pharmacy; Lippincott Williams & Wilkins, 2006, Vol. 1, .
[3]
Rama, R. Principles of Organic Medicinal Chemistry; New Age International: New Delhi, 2005, pp. 3-31.
[4]
Ceresole, R.; Moyano, M.; Pizzorno, M.; Segall, A. Validated Reversed Phase HPLC method for the determination of atenolol in the presence of its major degradation product. J. Liq. Chromatogr. Relat. Technol., 2006, 29(20), 3009-3019.
[http://dx.doi.org/10.1080/10826070600983393]
[5]
Elgawish, M.S.; Mostafa, S.M.; Elshanawane, A.A. Simple and rapid HPLC method for simultaneous determination of atenolol and chlorthalidone in spiked human plasma. Saudi Pharm. J., 2011, 19(1), 43-49.
[http://dx.doi.org/10.1016/j.jsps.2010.10.003] [PMID: 23960741]
[6]
El-Gindy, A.; Emara, S.; Mostafa, A. HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride and chlorthalidone. Farmaco, 2005, 60(3), 269-278.
[http://dx.doi.org/10.1016/j.farmac.2004.11.013] [PMID: 15784248]
[7]
Sivakumar, T.; Venkatesan, P.; Manavalan, R.; Valliappan, K. Development of a HPLC method for the simultaneous determination of losartan potassium and atenolol in tablets. Indian J. Pharm. Sci., 2007, 69(1), 154.
[http://dx.doi.org/10.4103/0250-474X.32137]
[8]
El-Gindy, A.; Sallam, S.; Abdel-Salam, R.A. HPLC method for the simultaneous determination of atenolol and chlorthalidone in human breast milk. J. Sep. Sci., 2008, 31(4), 677-682.
[http://dx.doi.org/10.1002/jssc.200700317] [PMID: 18266291]
[9]
Kumara, P.; Shuklab, S.; Ganurea, A.L.; Subudhia, B.B. Development and validation of a novel isocratic rp-hplc method for simultaneous determination of atenolol and aspirin in fixed dose combinations. Pharma Chem., 2011, 3(2), 13-21.
[10]
Kavitha, J.; Muralidharan, S.; Suresh, B. Development and validation of new method for atenolol, hydrochlorothiazide and losartan potassium by RP-HPLC: Its Application to routine quality control analysis. Int. J. Chemtech Res., 2010, 2(2), 880-884.
[11]
Elshanawane, A.A.; Mostafa, S.M.; Elgawish, M.S. Development and validation of a reversed-phase high-performance liquid chromatographic method for the simultaneous determination of amiloride hydrochloride, atenolol, hydrochlorothiazide, and chlorthalidone in their combined mixtures. J. AOAC Int., 2009, 92(2), 404-409.
[http://dx.doi.org/10.1093/jaoac/92.2.404] [PMID: 19485198]
[12]
El-Bagary, R.; Elkady, E.; Faqeh, A.J. Simultaneous determination of Atenolol, Amiloride hydrochloride and Hydrochlorothiazide using reversed phase liquid chromatography. J. Chem. Pharm. Res., 2011, 3, 320-329.
[13]
Ebeid, W.M.; Elkady, E.F.; El-Zaher, A.A.; El-Bagary, R.I.; Patonay, G. Synchronized separation of seven medications representing most commonly prescribed antihypertensive classes by using reversed-phase liquid chromatography: Application for analysis in their combined formulations. J. Sep. Sci., 2014, 37(7), 748-757.
[http://dx.doi.org/10.1002/jssc.201301298] [PMID: 24482404]
[14]
Youssef, R.M.; Maher, H.M.; El-Kimary, E.I.; Hassan, E.M.; Barary, M.H. Validated stability-indicating methods for the simultaneous determination of amiloride hydrochloride, atenolol, and chlorthalidone using HPTLC and HPLC with photodiode array detector. J. AOAC Int., 2013, 96(2), 313-323.
[http://dx.doi.org/10.5740/jaoacint.11-347] [PMID: 23767356]
[15]
Venkatesh, G.; Ramanathan, S.; Mansor, S.M.; Nair, N.K.; Sattar, M.A.; Croft, S.L.; Navaratnam, V. Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies. J. Pharm. Biomed. Anal., 2007, 43(4), 1546-1551.
[http://dx.doi.org/10.1016/j.jpba.2006.11.013] [PMID: 17157469]
[16]
Goebel, K.; Rolim, C.M.B. Validation of UV spectrophotometric and HPLC methods for quantitative determination of atenolol in pharmaceutical preparations. Lat. Am. J. Pharm., 2007, 26(5), 765-770.
[17]
Yilmaz, B.; Arslan, S.; Asci, A. HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey. J. Chromatogr. Sci., 2012, 50(10), 914-919.
[http://dx.doi.org/10.1093/chromsci/bms090] [PMID: 22718748]
[18]
Sultana, N.; Arayne, M.; Iftikhar, B. Simultaneous determination of atenolol, rosuvastatin, spironolactone, glibenclamide and naproxen sodium in pharmaceutical formulations and human plasma by RPHPLC. J. Chin. Chem. Soc. (Taipei), 2008, 55(5), 1022-1029.
[http://dx.doi.org/10.1002/jccs.200800149]
[19]
Delamoye, M.; Duverneuil, C.; Paraire, F.; de Mazancourt, P.; Alvarez, J-C. Simultaneous determination of thirteen β-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection. Forensic Sci. Int., 2004, 141(1), 23-31.
[http://dx.doi.org/10.1016/j.forsciint.2003.12.008] [PMID: 15066710]
[20]
Maitreyi, Z.; Khandhar, A. Development and Validation of a RP-HPLC for the Simultaneous estimation of Atenolol and Hydrochlorothiazide in Pharmaceutical Dosage Forms. Int. J. Adv. Pharmaceut. Sci., 2010, 2(3), 248-252.
[21]
Mohammed, N.S. Method development and validation of atenolol using two HPLC systems. Int. J. Pharm. Sci. Res., 2017, 8(6), 2706-2711.
[22]
Bhatia, N.M.; Gurav, S.B.; Jadhav, S.D.; Bhatia, M.S. RP-HPLC method for simultaneous estimation of Atorvastatin calcium, losartan potassium, atenolol, and Aspirin from tablet dosage form and plasma. J. Liq. Chromatogr. Relat. Technol., 2012, 35(3), 428-443.
[http://dx.doi.org/10.1080/10826076.2011.601495]
[23]
Argekar, A.P.; Powar, S.G. Simultaneous determination of atenolol and amlodipine in tablets by high-performance thin-layer chromatography. J. Pharm. Biomed. Anal., 2000, 21(6), 1137-1142.
[http://dx.doi.org/10.1016/S0731-7085(99)00210-1] [PMID: 10708397]
[24]
Argekar, A.; Sawant, J. Simultaneous determination of atenolol and nitrendipine in pharmaceutical dosage forms by HPTLC. J. Liq. Chromatogr. Relat. Technol., 1999, 22(10), 1571-1578.
[http://dx.doi.org/10.1081/JLC-100101752]
[25]
Prasad, C.V.; Parihar, C.; Sunil, K.; Parimoo, P. Simultaneous determination of amiloride HCl, hydrochlorothiazide and atenolol in combined formulations by derivative spectroscopy. J. Pharm. Biomed. Anal., 1998, 17(4-5), 877-884.
[http://dx.doi.org/10.1016/S0731-7085(97)00241-0] [PMID: 9682173]
[26]
Prasad, C.; Parihar, C.; Chowdhary, T.; Purohit, S.; Parimoo, P. Simultaneous Determination of Atenolol, Amlodipine and Haloperidol–Trihexyphenidyl in Combined Tablet Preparations by Derivative Spectroscopy. Pharm. Pharmacol. Commun., 1998, 4(7), 325-330.
[27]
Ferraro, M.C.; Castellano, P.M.; Kaufman, T.S. Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms. Anal. Bioanal. Chem., 2003, 377(7-8), 1159-1164.
[http://dx.doi.org/10.1007/s00216-003-2185-6] [PMID: 12955392]
[28]
Dey, S.; Sarkar, S.; Malakar, J.; Ghosh, A.; Gangopadhyay, A.; Mazumder, B. Spectrophotometric method for simultaneous determination of atenolol and atorvastatin in tablet dosage forms. Int. J. Pharm. Biomed. Res., 2012, 3, 40-43.
[29]
Rathee, P.; Rathee, S.; Thakur, S.; Kumar, V. Simultaneous estimation of amlodipine besylate and atenolol as api and in tablet dosage forms by vierodt’s method using uv spectrophotometry. Int. J. Chemtech Res., 2010, 2(1), 62-68.
[30]
Fernandes, N.; Nimdeo, M.; Choudhar, V.; Kulkarni, R.; Pande, V.; Nikalje, A. Dual wavelength and simultaneous equation spectrophotometric methods for estimation of atenolol and indapamide in their combined dosage form. Int J Chem Sci, 2008, 6(1), 29-35.
[31]
Bashir, N.; Shah, S.; Bangesh, M. A novel spectrophotometric determination of atenolol using sodium nitroprusside. NISCAIR-CSIR, India, 2011, 70(01), 51-54.
[32]
Choudhari, V.P.; Suryawanshi, V.M.; Mahabal, R.H.; Deshchougule, S.; Bhalerao, K.; Kuchekar, B. Simultaneous spectrophotometric estimation of Atenolol and Lercanidipine Hydrochloride in combined dosage form by ratio derivative and dual wavelength method. Int. J. Pharm. Sci. Rev. Res., 2010, 3, 73.
[33]
Kasture, A.; Ramteke, M. Simultaneous UV-Spectrophotometric methods for the estimation of Atenolol and Nifedipine in solid dosage forms. Indian J. Pharm. Sci., 2005, 67(6), 752.
[34]
Agarwal, S.; Singhal, V.; Prakash, A. Spectrophotometric determination of atenolol and timolol dosage forms via charge-transfer complexation. Indian J. Pharm. Sci., 1998, 60(1), 53.
[35]
Lalitha, K.; Kiranjyothi, R.; Padma, B.UV Spectrophotometric method development and validation for the determination of atenolol and losartan potassium by Q-analysis. Int. Bull. Drug Res., 2013, 3(4), 54-62.
[36]
Ferraro, M.C.; Castellano, P.M.; Kaufman, T.S. Chemometric determination of amiloride hydrochloride, atenolol, hydrochlorothiazide and timolol maleate in synthetic mixtures and pharmaceutical formulations. J. Pharm. Biomed. Anal., 2004, 34(2), 305-314.
[http://dx.doi.org/10.1016/S0731-7085(03)00521-1] [PMID: 15013144]
[37]
Abdine, H.; Sultan, M.A.; Hefnawy, M.M.; Belal, F. Spectrofluorometric determination of some β-blockers in tablets and human plasma using 9,10-dimethoxyanthracene-2-sodium sulfonate. Pharmazie, 2005, 60(4), 265-268.
[PMID: 15881605]
[38]
Basan, H.; Yarımkaya, S. A novel solid-phase extraction-spectrofluorimetric method for the direct determination of atenolol in human urine. Luminescence, 2014, 29(3), 225-229.
[http://dx.doi.org/10.1002/bio.2532] [PMID: 23733327]
[39]
Damiani, P.C. Determination of atenolol in human urine by emission-excitation fluorescence matrices and unfolded partial least-squares with residual bilinearization. Talanta, 2011, 85(3), 1526-1534.
[http://dx.doi.org/10.1016/j.talanta.2011.06.043] [PMID: 21807218]
[40]
Beitollahi, H.; Hamzavi, M.; Torkzadeh-Mahani, M. Electrochemical determination of hydrochlorothiazide and folic acid in real samples using a modified graphene oxide sheet paste electrode. Mater. Sci. Eng. C, 2015, 52, 297-305.
[http://dx.doi.org/10.1016/j.msec.2015.03.031] [PMID: 25953571]
[41]
Al Azzam, K.; Elbashir, A.A.; Elbashir, M.A.; Saad, B.; Abdul Hamid, S. Simultaneous determination of atenolol and chlorthalidone in pharmaceutical preparations by capillary-zone electrophoresis. Anal. Lett., 2009, 42(10), 1458-1470.
[http://dx.doi.org/10.1080/00032710902961065]
[42]
Al Azzam, K.M.; Saad, B.; Aboul-Enein, H.Y. Simultaneous determination of atenolol, chlorthalidone and amiloride in pharmaceutical preparations by capillary zone electrophoresis with ultraviolet detection. Biomed. Chromatogr., 2010, 24(9), 977-981.
[http://dx.doi.org/10.1002/bmc.1395] [PMID: 20066730]
[43]
Al Azzam, K.M.; Saad, B.; Aboul-Enein, H.Y. Simultaneous determination of atenolol and amiloride in pharmaceutical preparations by capillary zone electrophoresis with capacitively coupled contactless conductivity detection. Biomed. Chromatogr., 2010, 24(9), 948-953.
[http://dx.doi.org/10.1002/bmc.1390] [PMID: 20082285]
[44]
Mhaske, R.; Garole, D.; Mhaske, A.; Sahasrabudhe, S. RP-HPLC method for simultataneous determination of amlodipine besylate, valsartan, telmisartan, hydrochlorothiazide and chlorthalidone: application to commercially available drug products. Int. J. Pharm. Sci. Res., 2012, 3(1), 141.
[45]
Osman, R.; Elbashir, A. Development and Validation of Stability Indicating HPLC Method for the Simultaneous Analysis of Amlodipine, Hydrochlorothiazide and Valsartan in Pharmaceutical Formulation. J Anal. Pharm. Res., 2017, 6(5), 00188.
[46]
Ezzeldien, M.I.; Shokry, E.; Fouad, M.A.; Elbagary, R.I. Application of Chromatographic and Spectrophotometric Methods for The Analysis of Aliskiren and Hydrochlorothiazide Antihypertensive Combination. Int. J. Adv. Chem., 2013, 1(2), 13-20.
[http://dx.doi.org/10.14419/ijac.v1i2.1099]
[47]
Joshi, S.J.; Karbhari, P.A.; Bhoir, S.I.; Bindu, K.S.; Das, C. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation. J. Pharm. Biomed. Anal., 2010, 52(3), 362-371.
[http://dx.doi.org/10.1016/j.jpba.2009.10.021] [PMID: 19926421]
[48]
Tutunji, L.F.; Tutunji, M.F.; Alzoubi, M.I.; Khabbas, M.H.; Arida, A.I. Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies. J. Pharm. Biomed. Anal., 2010, 51(4), 985-990.
[http://dx.doi.org/10.1016/j.jpba.2009.10.023] [PMID: 20004542]
[49]
Sharma, R.N.; Pancholi, S.S. Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma. Acta Pharm., 2012, 62(1), 45-58.
[http://dx.doi.org/10.2478/v10007-012-0004-3] [PMID: 22472448]
[50]
Jain, P.S.; Patel, M.K.; Gorle, A.P.; Chaudhari, A.J.; Surana, S.J. Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form. J. Chromatogr. Sci., 2012, 50(8), 680-687.
[http://dx.doi.org/10.1093/chromsci/bms067] [PMID: 22593253]
[51]
Shaalan, R.A.; Belal, T.S.; El Yazbi, F.A.; Elonsy, S.M. Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets. Arab. J. Chem., 2017, 10, S1381-S1394.
[http://dx.doi.org/10.1016/j.arabjc.2013.04.012]
[52]
Kumaraswamy, G.; Sowmya, B.; Pranay, K. RP–HPLC method development and validation for simultaneous estimation of irbesartan, amlodipine and hydrochlorothiazide in bulk and laboratory dosage forms. Innovat International Journal Of Medical & Pharmaceutical Sciences, 2017, 2(7), 43-47.
[53]
Meyyanathan, S.N.; Rajan, S.; Muralidharan, S.; Birajdar, A.S.; Suresh, B. A validated RP-HPLC method for simultaneous estimation of nebivolol and hydrochlorothiazide in tablets. Indian J. Pharm. Sci., 2008, 70(5), 687-689.
[http://dx.doi.org/10.4103/0250-474X.45420] [PMID: 21394278]
[54]
Ebeid, W.M.; Elkady, E.F.; El-Zaher, A.A.; El-Bagary, R.I.; Patonay, G. Simultaneous determination of aliskiren hemifumarate, amlodipine besylate and hydrochlorothiazide in spiked human plasma using uplc-ms/ms. J. Chromatogr. Sci., 2015, 53(7), 1178-1184.
[http://dx.doi.org/10.1093/chromsci/bmu213] [PMID: 25575509]
[55]
Lotfy, H.M.; Hegazy, M.A.; Mowaka, S.; Mohamed, E.H. Novel spectrophotometric methods for simultaneous determination of Amlodipine, Valsartan and Hydrochlorothiazide in their ternary mixture. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2015, 140, 495-508.
[http://dx.doi.org/10.1016/j.saa.2014.12.096] [PMID: 25638433]
[56]
Sayyed, Z.; Shinde, S.; Chaware, V.; Chaudhari, B.; Biyani, K. Development and validation of UV-spectrophotometric method for simultaneous estimation of amlodipine besylate and hydrochlorothiazide in combined dosage form including stability study. J. Pharm. Sci., 2015.
[57]
El-Bagary, R.I.; Hashem, H.M.; Elkady, E.F.; Ebeid, W.A. Chemometric assisted spectrophotometric and stability indicating lc methods for the determination of candesartan cilexetil and hydrochlorothiazide in their combined formulation. Inventi Rapid: Pharm Analysis &. Qual. Assur., 2013.
[58]
Ebeid, W.; Salim, M.; Elkady, E.; Elzahr, A.; El-Bagary, R.; Patonay, G. Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE). Pharmazie, 2015, 70(6), 368-373.
[PMID: 26189296]
[59]
Abdelwahab, N.S. Spectrophotometric methods for simultaneous determination of Carvedilol and Hydrochlorothiazide in combined dosage form. Arab. J. Chem., 2016, 9, S355-S360.
[http://dx.doi.org/10.1016/j.arabjc.2011.05.002]
[60]
Mostafa, A.; El-Gindy, A.; Emara, S. Simultaneous Spectrophotometric estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation using partial least-squares, principal component regression multivariate calibrations and RP-HPLC Methods. J Anal Pharm Res, 2017, 4(6), 00124.
[http://dx.doi.org/10.15406/japlr.2017.04.00124]
[61]
Merey, H.A.; Ramadan, N.K.; Diab, S.S.; Moustafa, A.A. Spectrophotometric methods for simultaneous determination of ternary mixture of amlodipine besylate, olmesartan medoxomil and hydrochlorothiazide. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2014, 125, 138-146.
[http://dx.doi.org/10.1016/j.saa.2014.01.095] [PMID: 24534425]
[62]
Kumar, J.S.P.; Annapurna, M.M. New Spectrophotometric Methods for the Simultaneous Determination of Irbesartan and Hydrochlorothiazide in Combined Dosage Forms. Pharm. Methods, 2015, 6(3), 120-125.
[http://dx.doi.org/10.5530/phm.2015.6.18]
[63]
Sayyed, Z.; Shinde, S.; Chaware, V.; Chaudhari, B. Development and Validation of UV-Spectrophotometric Method for Simultaneous Estimation of Spironolactone and Hydrochlorothiazide in Pharmaceutical Formulation. J. Pharm. Sci., 2015, 5(6), 590-593.
[64]
Mhaske, R.; Sahasrabudhe, S.; Mhaske, A. RP-HPLC method for simultataneous determination of irbesartan, losartan, hydrohlorothiazide and chlorthalidone-application to commercially available drug products. Int. J. Pharm. Sci. Res., 2012, 3(4), 1116.
[65]
Dangre, P.; Sawale, V.; Meshram, S.; Gunde, M. Development and validation of RP-HPLC method for the Simultaneous Estimation of Eprosartan mesylate and chlorthalidone in Tablet Dosage Form. Int. J. Pharm. Tech. Res., 2015, 8(2), 163-168.
[66]
Ebeid, W.M.; Elkady, E.F.; El-Zaher, A.A.; El-Bagary, R.I.; Patonay, G. Stability-indicating RP-LC method for determination of azilsartan medoxomil and chlorthalidone in pharmaceutical dosage forms: application to degradation kinetics. Anal. Bioanal. Chem., 2014, 406(26), 6701-6712.
[http://dx.doi.org/10.1007/s00216-014-8085-0] [PMID: 25190009]
[67]
Herráez-Hernández, R.; Campíns-Falcó, P. Chromatographic separation of chlorthalidone enantiomers using β-cyclodextrins as chiral additives. J. Chromatogr. B Biomed. Sci. Appl., 2000, 740(2), 169-177.
[http://dx.doi.org/10.1016/S0378-4347(00)00103-1] [PMID: 10821402]
[68]
Naazneen, S.; Sridevi, A. Stability-indicating RP-HPLC method for the simultaneous estimation of azilsartan medoxomil and chlorthalidone in solid dosage forms. Int. J. Pharm. Pharm. Sci., 2014, 6(6), 236-243.
[69]
Singh, B.; Patel, D.; Ghosh, S. A reversed-phase high performance liquid chromatographic method for determination of chlorthalidone in pharmaceutical formulation. Int. J. Pharm. Pharm. Sci., 2009, 1(2), 24-29.
[70]
Walters, S.M.; Stonys, D.B. Determination of chlorthalidone and clonidine hydrochloride in tablets by HPLC. J. Chromatogr. Sci., 1983, 21(1), 43-45.
[http://dx.doi.org/10.1093/chromsci/21.1.43] [PMID: 6833444]
[71]
Parmar, K.E.; Patel, N.D. Stability indicating RP-HPLC Method for Simultaneous determination of telmisartan and chlorthalidone in bulk and pharmaceutical dosage form. Int. J. Pharm. Tech. Res., 2013, 5, 1728-1735.
[72]
Surwase, B.H.; Tapkir, A.S.; Jadhav, S.B.; Chaudhari, P.D. Development and validation of RP-HPLC method for simultaneous estimation of telmisartan and chlorthalidone in bulk and tablet dosage form. Scholar Research Library, 2013, 5(1), 149-154.
[73]
Kudumula, N.; Prasad, Y.R. Development and validation of RP-HPLC Method for the Simultaneous estimation of chlorthalidone and cilnidipine in bulk and combined tablet dosage form. Pharmacophore, 2014, 5(4), 442-450.
[74]
Dave, V.; Maheshwari, D.G. RP-HPLC method for simultaneous estimation of enalapril maleate and chlorthalidone in synthetic mixture. Int. J. Pharm. Sci. Res., 2015, 6(4), 666-673.
[75]
Abdullah, N.S.; Hassan, M.A.; Hassan, R.O. Spectrophotometric determination of chlorthalidone in pharmaceutical formulations using different order derivative methods. Arab. J. Chem., 2017, 10, S3426-S3433.
[http://dx.doi.org/10.1016/j.arabjc.2014.02.002]
[76]
Ebeid, W.M.; Elkady, E.F.; El-Zaher, A.A.; El-Bagary, R.I.; Patonay, G. Spectrophotometric and spectrofluorimetric studies on azilsartan medoxomil and chlorthalidone to be utilized in their determination in pharmaceuticals. Anal. Chem. Insights, 2014, 9, 33-40.
[http://dx.doi.org/10.4137/ACI.S13768] [PMID: 24855334]
[77]
Patel, S.N.; Hinge, M.A.; Bhanushali, V.M. Development and validation of an UV spectrophotometric method for simultaneous determination of cilnidipine and chlorthalidone. J. Pharm. Res., Vol, 2015, 9(1), 41-45.
[78]
Patel, D.; Patel, C. Estimation of Metoprolol Tartrate and Chlorthalidone in Combined Dosage Form by UV-Spectrophotometric Methods. Indian J. Pharm. Technol., 2011, 4(8), 1204-1206.
[79]
Luis, M.L.; García, J.M.; Jiménez, F.; Jiménez, A.I.; Arias, J.J. Simultaneous determination of chlorthalidone and spironolactone with univariate and multivariate calibration: wavelength range selection. J. AOAC Int., 1999, 82(5), 1054-1063.
[http://dx.doi.org/10.1093/jaoac/82.5.1054] [PMID: 10513007]
[80]
Michael, E.; Ahmad, A.A.; Salem, H.; Omar, M.A. Spectrophotometric and spectro-fluorimetric determination of certain diuretics in pure forms and in their pharmaceutical formulations. Bull. Pharm. Sci., 2006, 29(1), 33-58.
[81]
Balesteros, M.R.; Faria, A.F.; de Oliveira, M.A. Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis. J. Braz. Chem. Soc., 2007, 18(3), 554-558.
[http://dx.doi.org/10.1590/S0103-50532007000300009]
[82]
Pharmacopoeia, B. British pharmacopoeia; , 2016, Vol. I, .
[83]
Pharmacopoeia, The US Pharmacopoeia 34 NF 29 2011, II
[84]
Sa’Sa’, S.; Jalal, I.; Khalil, H. Determination of atenolol combinations with hydrochlorothiazide and chlorthalidone in tablet formulations by reverse-phase HPLC. J. Liq. Chromatogr., 1988, 11(8), 1673-1696.
[http://dx.doi.org/10.1080/01483918808076729]
[85]
Naguib, I.A.; Abdelaleem, E.A.; Zaazaa, H.E.; Draz, M.E. Simultaneous determination of hydrochlorothiazide and benazepril hydrochloride or amiloride hydrochloride in presence of hydrochlorothiazide impurities: chlorothiazide and salamide by HPTLC method. J. Chromatogr. Sci., 2015, 53(1), 183-188.
[http://dx.doi.org/10.1093/chromsci/bmu016] [PMID: 24771053]
[86]
El-Bagary, R.I.; Fouad, M.A.; El-Shal, M.A.; Tolba, E.H. Forced degradation of mometasone furoate and development of two RP-HPLC methods for its determination with formoterol fumarate or salicylic acid. Arab. J. Chem., 2016, 9(3), 493-505.
[http://dx.doi.org/10.1016/j.arabjc.2015.05.005]
[87]
Abdelwahab, N.S. Determination of atenolol, chlorthalidone and their degradation products by TLC-densitometric and chemometric methods with application of model updating. Anal. Methods, 2010, 2(12), 1994-2001.
[http://dx.doi.org/10.1039/c0ay00374c]
[88]
El-Bagary, R.I.; Elkady, E.F.; Tammam, M.H.; Elmaaty, A.A. Simul-taneous determination of miconazole and hydrocortisone or mometasone using reversed phase liquid chromatography. Eur. J. Chem., 2012, 3(4), 421-425.
[http://dx.doi.org/10.5155/eurjchem.3.4.421-425.667]
[89]
ICHT., Validation of Analytical Procedures: Methodology (CPMP/ICH/281/95). Step 4. Consensus Guideline. The European Agency for the Evaluation of Medicinal Products London, UK 1996.
[90]
Pharmacopeia, U. General Notices and Requirements Applying to Standards, Tests, Assays, and Other Specifications of the United States Pharmacopeia USP 33-NF 28 Reissue 2015.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 8
Year: 2020
Published on: 27 September, 2020
Page: [1037 - 1051]
Pages: 15
DOI: 10.2174/1573412915666190523122525
Price: $65

Article Metrics

PDF: 23
HTML: 1